Zhang Yu-Xuan, Li Bo-Shen, Fan Rong-Hui, Li Xiao-Lin, Li Mao-Xing
Institute of Radiation Medicine Sciences, Academy of Military Medical, Academy of Military Sciences Beijing 100850, China the PLA Highland Medical Laboratory, the 940th Hospital of Joint Logistic Support Force of Chinese People's Liberation Army Lanzhou 730050, China College of Pharmacy, Gansu University of Chinese Medicine Lanzhou 730000, China.
the PLA Highland Medical Laboratory, the 940th Hospital of Joint Logistic Support Force of Chinese People's Liberation Army Lanzhou 730050, China College of Pharmacy, Gansu University of Chinese Medicine Lanzhou 730000, China.
Zhongguo Zhong Yao Za Zhi. 2023 Jun;48(12):3394-3403. doi: 10.19540/j.cnki.cjcmm.20230226.503.
This study retrieved Croci Stigma related literature from CNKI, Wanfang, VIP, and Web of Science database, and used bibliometrics and CiteSpace 6.1.R2 software to analyze the published Croci Stigma related articles in Chinese and English from 2000 to 2022. The authors, research institutions, and keywords were visualized and analyzed, and the current status and development trend of Croci Stigma research was summarized by combining the information extraction methods. A total of 1 846 Chinese articles and 2 703 English articles were screened out and included. The results showed a generally steady increase in the number of Croci Stigma related articles. The results of the visualization analysis showed that there were more collaborations between researcher teams and major research institutions in English articles than Chinese articles. The Chinese articles was mainly published by China Pharmaceutical University, and most of the inter-institutional collaborations occurred in neighboring regions. The English articles was mainly published by Iranian institutions, and most of the cooperation occurred within the country, with less transnational cooperation. Keywords analysis showed that the research on Croci Stigma was mainly focused on chemical compositions, pharmacological effects, mechanisms, quality control, etc. It was predicted that the future research hotspots of Croci Stigma would mainly focus on pharmacological mechanism and clinical efficacy. The current research related to Croci Stigma still needs to be developed, cooperation should be strengthened, and more in-depth research should be conducted.
本研究从中国知网、万方、维普和Web of Science数据库中检索藏红花相关文献,运用文献计量学方法并借助CiteSpace 6.1.R2软件,对2000年至2022年发表的中英文藏红花相关文章进行分析。对作者、研究机构和关键词进行可视化分析,并结合信息提取方法总结藏红花研究的现状和发展趋势。共筛选纳入1846篇中文文章和2703篇英文文章。结果显示,藏红花相关文章数量总体呈稳步增长趋势。可视化分析结果表明,英文文章中研究团队与主要研究机构之间的合作比中文文章更多。中文文章主要由中国药科大学发表,机构间合作大多发生在相邻地区。英文文章主要由伊朗机构发表,合作大多在国内进行,跨国合作较少。关键词分析表明,藏红花研究主要集中在化学成分、药理作用、作用机制、质量控制等方面。预计藏红花未来的研究热点将主要集中在药理机制和临床疗效方面。目前藏红花相关研究仍有待发展,应加强合作并开展更深入的研究。
Zhongguo Zhong Yao Za Zhi. 2023-6
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2023-10-20
Zhonghua Yan Ke Za Zhi. 2024-2-11
Zhongguo Zhong Yao Za Zhi. 2022-6
Zhongguo Zhong Yao Za Zhi. 2022-2
Zhongguo Zhong Yao Za Zhi. 2022-8
Fa Yi Xue Za Zhi. 2022-2-25
Zhonghua Shao Shang Za Zhi. 2021-3-20
Zhongguo Zhong Yao Za Zhi. 2022-4
Zhongguo Zhong Yao Za Zhi. 2021-3